Approval · United States
Mounjaro
U.S. Food and Drug Administration · May 13, 2022
Approval record
- Asset
- Tirzepatide
- Brand name
- Mounjaro
- Generic name
- tirzepatide
- Indication
- Type 2 diabetes
- Jurisdiction
- United States
- Regulator
- U.S. Food and Drug Administration
- Approval date
- May 13, 2022
- Company
- Eli Lilly
Sources
- regulatoryprimary record
FDA approves Mounjaro (tirzepatide) for adults with type 2 diabetes
U.S. Food and Drug Administration · FDA News Release · May 13, 2022